Osteoporosis knowledge, health beliefs, and healthy bone behaviours in patients on androgen-deprivation therapy (ADT) for prostate cancer

BJU International

Volumn 111, Issue 8, 2013, Pages 1301-1309

  Nadler, Michelle ^a   Alibhai, Shabbir ^a   Catton, Pamela ^a   Catton, Charles ^a   To, Matthew J ^a   Jones, Jennifer M ^a  

^a PRINCESS MARGARET HOSPITAL   (Canada)

Author keywords

androgen deprivation therapy; bone mineral density; health beliefs; healthy bone behaviours; knowledge; osteoporosis; prostate cancer

Indexed keywords

CALCIUM; VITAMIN D;

ADULT; AGED; ANDROGEN DEPRIVATION THERAPY; ARTICLE; DUAL ENERGY X RAY ABSORPTIOMETRY; EDUCATIONAL STATUS; EXERCISE; FRAGILITY FRACTURE; HEALTH BEHAVIOR; HEALTH BELIEF; HEALTH BELIEF MODEL; HUMAN; MAJOR CLINICAL STUDY; MALE; MOTIVATION; OSTEOPENIA; OSTEOPOROSIS; PRIORITY JOURNAL; PROSTATE CANCER; SELF CONCEPT; VITAMIN INTAKE;

ABSORPTIOMETRY, PHOTON; AGED; AGED, 80 AND OVER; ANDROGEN ANTAGONISTS; BONE DENSITY; FOLLOW-UP STUDIES; HEALTH BEHAVIOR; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; PATIENT EDUCATION AS TOPIC; PROSTATIC NEOPLASMS; RETROSPECTIVE STUDIES;

EID: 84878333371     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2012.11777.x     Document Type: Article

References (64)

1. Canadian Cancer Society. Canadian Cancer Statistics 2008 (On-line). 2008; Available at: http://www.cancer.ca/canada-wide/about%20cancer/ cancer%20statistics/~/media/CCS/Canada%20wide/Files%20List/ English%20files%20heading/pdf%20not%20in%20publications%20section/ Canadian%20Cancer%20Society%20Statistics%20PDF%202008-614137951.ashx. Accessed December 2012
2. American Cancer Society. Cancer Facts & Figures 2010. Atlanta: American Cancer Society, 2010. Available at: http://www.cancer.org/acs/groups/ content/@nho/documents/document/acspc-024113.pdf. Accessed December 2012
3. Taylor LG, Canfield SE, Du XL,. Review of major adverse effects of androgen deprivation therapy in men with prostate cancer. Cancer 2009; 115: 2388-2399
4. Canadian Cancer Society. Prostate cancer statistics. 2010 [updated 19 May 2010; cited 15 February 2011]. Available at: http://www.ncic.cancer.ca/Ontario/ About%20cancer/Cancer%20statistics/Stats%20at%20a%20glance/Prostate%20cancer. aspx?sc-lang=en&r=1. Accessed December 2012
5. Jacobs LA, Palmer SC, Schwartz LA, et al. Adult cancer survivorship: evolution, research, and planning care. CA Cancer J Clin 2009; 59: 391-410
6. Saylor PJ, Keating NL, Smith MR,. Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy. J Gen Intern Med 2009; 24 (Suppl. 2): S389-394
7. D'Amico AV, Chen MH, Renshaw AA, Loffredo M, Kantoff PW,. Androgen suppression and radiation vs radiation alone for prostate cancer: a randomized trial. JAMA 2008; 299: 289-295 (Pubitemid 351159365)
8. Roach M 3rd, Bae K, Speight J, et al. Short-term neoadjuvant androgen deprivation therapy and external-beam radiotherapy for locally advanced prostate cancer: long-term results of RTOG 8610. J Clin Oncol 2008; 26: 585-591 (Pubitemid 351264352)
9. Alibhai SM, Gogov S, Allibhai Z,. Long-term side effects of androgen deprivation therapy in men with non-metastatic prostate cancer: a systematic literature review. Crit Rev Oncol Hematol 2006; 60: 201-215 (Pubitemid 44709617)
10. Alibhai SM, Duong-Hua M, Cheung AM, et al. Fracture types and risk factors in men with prostate cancer on androgen deprivation therapy: a matched cohort study of 19,079 men. J Urol 2010; 184: 918-923
11. Gralow JR, Biermann JS, Farooki A, et al. NCCN Task Force Report: bone health in cancer care. J Natl Compr Canc Netw 2009; 7 (Suppl. 3): S1-32
12. Michaud LB,. Managing cancer treatment-induced bone loss and osteoporosis in patients with breast or prostate cancer. Am J Health Syst Pharm 2010; 67 (Suppl. 3): S20-30
13. D'Alesio V, Salvig BE, Fourakre TN,. Evaluation of osteoporosis risk assessment in veterans receiving androgen-deprivation therapy. Consult Pharm 2011; 26: 43-47
14. Shahinian VB, Kuo YF, Freeman JL, Goodwin JS,. Risk of fracture after androgen deprivation for prostate cancer. N Engl J Med 2005; 352: 154-164 (Pubitemid 40096612)
15. Serpa Neto A, Tobias-Machado M, Esteves MA, et al. A systematic review and meta-analysis of bone metabolism in prostate adenocarcinoma. BMC Urol 2010; 10: 9
16. Greenspan SL, Coates P, Sereika SM, Nelson JB, Trump DL, Resnick NM,. Bone loss after initiation of androgen deprivation therapy in patients with prostate cancer. J Clin Endocrinol Metab 2005; 90: 6410-6417 (Pubitemid 41759293)
17. Israeli RS, Ryan CW, Jung LL,. Managing bone loss in men with locally advanced prostate cancer receiving androgen deprivation therapy. J Urol 2008; 179: 414-423
18. Lattouf JB, Saad F,. Bone complications of androgen deprivation therapy: screening, prevention, and treatment. Curr Opin Urol 2010; 20: 247-252
19. Fink HA, Ensrud KE, Nelson DB, et al. Disability after clinical fracture in postmenopausal women with low bone density: the fracture intervention trial (FIT). Osteoporosis Int 2003; 14: 69-76 (Pubitemid 36267903)
20. Oefelein MG, Ricchiuti V, Conrad W, Resnick MI,. Skeletal fractures negatively correlate with overall survival in men with prostate cancer. J Urol 2002; 168: 1005-1007
21. Hamdy RC, Baim S, Broy SB, et al. Algorithm for the management of osteoporosis. South Med J 2010; 103: 1009-1015
22. Tosteson AN, Melton LJ 3rd, Dawson-Hughes B, et al. Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporosis Int 2008; 19: 437-447
23. Papaioannou A, Morin S, Cheung AM, et al. 2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary. CMAJ 2010; 182: 1864-1873
24. Watts NB, Adler RA, Bilezikian JP, et al. Osteoporosis in men: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2012; 97: 1802-1822
25. VanderWalde A, Hurria A,. Aging and osteoporosis in breast and prostate cancer. CA Cancer J Clin 2011; 61: 139-156
26. Duncan GG, Corbett T, Lukka H, Warde P, Pickles T,. GU radiation oncologists consensus on bone loss from androgen deprivation. Can J Urol 2006; 13: 2962-2966
27. Adler RA,. Management of osteoporosis in men on androgen deprivation therapy. Maturitas 2011; 68: 143-147
28. Ito K, Elkin EB, Girotra M, Morris MJ,. Cost-effectiveness of fracture prevention in men who receive androgen deprivation therapy for localized prostate cancer. Ann Intern Med 2010; 152: 621-629
29. Bischoff-Ferrari HA, Dawson-Hughes B, Staehelin HB, et al. Fall prevention with supplemental and active forms of vitamin D: a meta-analysis of randomised controlled trials. BMJ 2009; 339: b3692
30. Sherrington C, Whitney JC, Lord SR, Herbert RD, Cumming RG, Close JC,. Effective exercise for the prevention of falls: a systematic review and meta-analysis. J Am Geriatr Soc 2008; 56: 2234-2243
31. Galvao DA, Taaffe DR, Spry N, Joseph D, Newton RU,. Combined resistance and aerobic exercise program reverses muscle loss in men undergoing androgen suppression therapy for prostate cancer without bone metastases: a randomized controlled trial. J Clin Oncol 2010; 28: 340-347
32. Kim KK, Horan ML, Gendler P, Patel MK,. Development and evaluation of the Osteoporosis Health Belief Scale. Res Nurs Health 1991; 14: 155-163
33. Rosenstock IM,. Why people use health services. Milbank Mem Fund Q 1966; 44 (Suppl).): 94-127
34. Rosenstock IM, Strecher VJ, Becker MH,. Social learning theory and the Health Belief Model. Health Educ Q 1988; 15: 175-183
35. McLeod KM, Johnson CS,. A systematic review of osteoporosis health beliefs in adult men and women. J Osteoporos 2011; 2011: 197454
36. Alibhai SM, Yun L, Cheung AM, Paszat L,. Screening for osteoporosis in men receiving androgen deprivation therapy. JAMA 2012; 307: 255-256
37. Panju AH, Breunis H, Cheung AM, et al. Management of decreased bone mineral density in men starting androgen-deprivation therapy for prostate cancer. BJU Int 2009; 103: 753-757
38. Al-Shamsi HO, Lau AN, Malik K, et al. The current practice of screening, prevention, and treatment of androgen-deprivation-therapy induced osteoporosis in patients with prostate cancer. J Oncol 2012; 2012: 958596
39. Van Tongeren LS, Duncan GG, Kendler DL, Pai H,. Implementation of osteoporosis screening guidelines in prostate cancer patients on androgen ablation. J Clin Densitom 2009; 12: 287-291
40. Tanvetyanon T,. Physician practices of bone density testing and drug prescribing to prevent or treat osteoporosis during androgen deprivation therapy. Cancer 2005; 103: 237-241 (Pubitemid 40129281)
41. Ali NS, Shonk C, El-Sayed MS,. Bone health in men: influencing factors. Am J Health Behav 2009; 33: 213-222
42. Walker LM, Tran S, Wassersug RJ, Thomas B, Robinson JW,. Patients and partners lack knowledge of androgen deprivation therapy side effects. Urol Oncol 2012; 11: 00475-3
43. Canadian Society for Exercise P. Canadian Physical Activity Guidelines. 2012 [cited 2011 June]. Available at: http://www.csep.ca/english/view.asp?x=804. Accessed December 2012
44. Magkos F, Manios Y, Babaroutsi E, Sidossis LS,. Development and validation of a food frequency questionnaire for assessing dietary calcium intake in the general population. Osteoporos Int 2006; 17: 304-312 (Pubitemid 43053596)
45. Godin G,. Godin Leisure-Time Exercise Questionnaire. Med Sci Sports Exerc 1997; 29 (June Suppl).): S36-38
46. Ailinger RL, Lasus H, Braun MA,. Revision of the facts on osteoporosis quiz. Nurs Res 2003; 52: 198-201
47. Gaines JM, Marx KA, Narrett M, Caudill J, Landsman J, Parrish JM,. Validation of the male osteoporosis knowledge quiz. Am J Mens Health 2011; 5: 78-83
48. Horan ML, Kim KK, Gendler P, Froman RD, Patel MD,. Development and evaluation of the Osteoporosis Self-Efficacy Scale. Res Nurs Health 1998; 21: 395-403 (Pubitemid 128454582)
49. Gaines JM, Marx KA,. Older men's knowledge about osteoporosis and educational interventions to increase osteoporosis knowledge in older men: a systematic review. Maturitas 2011; 68: 5-12
50. Zittermann A, Pilz S, Borgermann J, Gummert JF,. Calcium supplementation and vitamin D: a trigger for adverse cardiovascular events? Future Cardiol 2011; 7: 725-727
51. Bolland MJ, Avenell A, Baron JA, et al. Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis. BMJ 2011; 342: d2040
52. Ioannidis G, Thabane L, Gafni A, et al. Optimizing care in osteoporosis: the Canadian quality circle project. BMC Musculoskelet Disord 2008; 9: 130
53. Ioannidis G, Papaioannou A, Thabane L, et al. The utilization of appropriate osteoporosis medications improves following a multifaceted educational intervention: the Canadian quality circle project (CQC). BMC Med Educ 2009; 9: 54
54. Canada O,. Calculate My Calcium. 2011 [cited 2012 July 13]; Calcium Calculation Tool]. Available at: http://www.osteoporosis.ca/. Accessed December2012
55. Laslett LL, Lynch J, Sullivan TR, McNeil JD,. Osteoporosis education improves osteoporosis knowledge and dietary calcium: comparison of a 4 week and a one-session education course. Int J Rheum Dis 2011; 14: 239-247
56. Francis KL, Matthews BL, Van Mechelen W, Bennell KL, Osborne RH,. Effectiveness of a community-based osteoporosis education and self-management course: a wait list controlled trial. Osteoporos Int 2009; 20: 1563-1570
57. Drieling RL, Ma J, Thiyagarajan S, Stafford RS,. An Internet-based osteoporotic fracture risk program: effect on knowledge, attitudes, and behaviors. J Womens Health (Larchmt) 2011; 20: 1895-1907
58. Aree-Ue S, Pothiban L, Belza B, Sucamvang K, Panuthai S,. Osteoporosis preventive behavior in Thai older adults: feasibility and acceptability. J Gerontol Nurs 2006; 32: 23-30
59. Marci CD, Anderson WB, Viechnicki MB, Greenspan SL,. Bone mineral densitometry substantially influences health-related behaviors of postmenopausal women. Calcif Tissue Int 2000; 66: 113-118 (Pubitemid 30056705)
60. Brask-Lindemann D, Cadarette SM, Eskildsen P, Abrahamsen B,. Osteoporosis pharmacotherapy following bone densitometry: importance of patient beliefs and understanding of DXA results. Osteoporosis Int 2011; 22: 1493-1501
61. Doheny MO, Sedlak CA, Estok PJ, Zeller RA,. Bone density, health beliefs, and osteoporosis preventing behaviors in men. Orthop Nurs 2011; 30: 266-272
62. Doheny MO, Sedlak CA, Hall RJ, Estok PJ,. Structural model for osteoporosis preventing behavior in men. Am J Mens Health 2010; 4: 334-343
63. Patel A, Coates PS, Nelson JB, Trump DL, Resnick NM, Greenspan SL,. Does bone mineral density and knowledge influence health-related behaviors of elderly men at risk for osteoporosis? J Clin Densitom 2003; 6: 323-330
64. Holick MF, Binkley NC, Bischoff-Ferrari HA, et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab 2011; 96: 1911-1930